SeaStar Medical Holding Corporation (ICU) Stock Forecast & Price Target
SeaStar Medical Holding Corporation · NASDAQ
$3.14-0.04 (-1.26%)
15-min delayed · Aug 26, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 1 firms covering SeaStar Medical Holding Corporation, 1 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets are tightly clustered, $8.00 to $8.00, so the covering firms are broadly aligned. The average target of $8.00 sits 155% above the current $3.14. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.89 next quarter toward $-2.33 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS1 ratings
Strong Buy
Strong Buy00%
Buy1100%
Hold00%
Sell00%
Strong Sell00%
Based on 1 analysts giving stock ratings to SeaStar Medical Holding Corporation.
As of Aug, 1 of 1 firms rate ICU a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
ICU EPS & revenue forecast
EPS · NEXT QUARTER
$-0.89
Range $-0.89 – $-0.89 · 1 analysts · +11% YoY
Next period, 1 analysts expect SeaStar Medical Holding Corporation to earn $-0.89 a share (range $-0.89 – $-0.89), versus $-0.80 a year earlier. Full-year consensus is $-3.66, growing to $-2.33 the year after.
REVENUE · NEXT QUARTER
$500.0K
Range $500.0K – $500.0K · 1 analysts · +19% YoY
Revenue is expected to reach $500.0K (range $500.0K – $500.0K), +19.0% year-over-year. Full-year consensus is $2.0M, rising to $2.9M next year.
Top analysts covering SeaStar Medical Holding Corporation
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ICU.
#1
Anthony Vendetti
Maxim Group · Rank #350
Buy
$8.00+154.8% to target
Overall win rate
29%
+ Follow
ICU stock forecast FAQ
What is ICU's average 12-month price target?+
The 1 analysts with a live target average $8.00 for SeaStar Medical Holding Corporation over the next 12 months, ranging from a $8.00 high to a $8.00 low.
Is ICU stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 1 analyst ratings, 1 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
How many Wall Street analysts cover ICU?+
1 analysts have an active rating on SeaStar Medical Holding Corporation, and 1 firms carry a live 12-month price target.
Who is the most accurate analyst covering ICU?+
Among analysts who currently cover ICU, Anthony Vendetti of Maxim Group has the strongest overall Quantellect track record (Rank #350). Their current call is Buy with a $8.00 target.
What is SeaStar Medical Holding Corporation's projected EPS for next quarter?+
The consensus estimate is $-0.89 per share (range $-0.89 – $-0.89) across 1 analysts. Full-year EPS is projected at $-3.66, rising to $-2.33 the following year.
How much revenue is SeaStar Medical Holding Corporation expected to report next quarter?+
Consensus revenue is $500.0K (range $500.0K – $500.0K). Full-year revenue is projected at $2.0M, growing to $2.9M next year.
Have analysts been upgrading or downgrading ICU lately?+
As of Aug, 1 of 1 firms rate ICU a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ICU calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
